Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
STREAMLINE HEALTH SOLUTIONS INC. (STRM)
|
Add to portfolio |
|
|
|
| Price: |
$2.20
| | Metrics |
| OS: |
57.4
|
M
| |
|
|
| Market cap: |
$126
|
M
| |
|
|
|
Net cash:
|
$5.11
|
M
| |
$0.09
|
per share
|
|
EV:
|
$121
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($7.1)
|
M
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Jan-31-22 | Jan-31-21 | Jan-31-20 | Jan-31-19 | Jan-31-18 | Jan-31-17 | Jan-31-16 | Jan-31-15 |
| Revenues | 17.4 | 11.3 | 20.7 | 22.4 | 24.3 | 27.1 | 28.3 | 27.6 |
| Revenue growth | 53.2% | -45.3% | -7.3% | -8.1% | -10.1% | -4.4% | 2.5% | -3.1% |
| Cost of goods sold | 3.3 | 1.5 | 4.0 | 3.6 | 2.4 | 8.7 | 9.0 | 10.1 |
| Gross profit | 14.1 | 9.8 | 16.8 | 18.8 | 21.9 | 18.4 | 19.4 | 17.5 |
| Gross margin | 81.2% | 86.4% | 80.8% | 83.9% | 90.1% | 68.0% | 68.4% | 63.5% |
| Selling, general and administrative | 11.9 | 8.6 | 9.8 | 10.6 | 11.4 | 13.1 | 13.4 | 16.2 |
| Research and development | 4.8 | 2.9 | 3.6 | 4.3 | 5.4 | 7.5 | 9.1 | 9.8 |
| EBITA | -9.5 | -5.4 | -1.0 | -0.7 | -1.5 | -3.4 | -4.3 | -10.0 |
| EBITA margin | -54.6% | -47.2% | -4.6% | -3.1% | -6.0% | -12.7% | -15.1% | -36.1% |
| Amortization of intangibles | 1.3 | 0.5 | 0.6 | 0.9 | 1.2 | 1.3 | 1.3 | 1.4 |
| EBIT | -10.8 | -5.8 | -1.5 | -1.6 | -2.6 | -4.8 | -5.6 | -11.4 |
| EBIT margin | -62.0% | -51.5% | -7.3% | -7.2% | -10.8% | -17.6% | -19.9% | -41.1% |
| Pre-tax income | -6.8 | -6.1 | -2.8 | -5.9 | -3.2 | -5.2 | -4.3 | -12.9 |
| Income taxes | 0.1 | -1.3 | 0.0 | 0.0 | -0.1 | 0.0 | 0.0 | -0.9 |
| Tax rate | | 20.8% | | 0.0% | 2.6% | 0.2% | | 6.9% |
| Earnings from continuing ops | -6.9 | -4.8 | 2.0 | -5.9 | -3.1 | -6.0 | -5.6 | -13.0 |
| Earnings from discontinued ops | 0.4 | 11.1 | | | | | | |
| Net income | -6.5 | 0.3 | 2.0 | -5.9 | -3.1 | -6.0 | -5.6 | -13.0 |
| Net margin | -37.6% | 2.6% | 9.8% | -26.2% | -12.7% | -22.3% | -19.9% | -47.2% |
| |
| Diluted EPS | ($0.16) | ($0.16) | $0.09 | ($0.30) | ($0.16) | ($0.31) | ($0.30) | ($0.71) |
| Shares outstanding (diluted) | 43.3 | 30.6 | 22.7 | 19.5 | 19.1 | 19.5 | 18.7 | 18.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|